Exclusive: Lonza expects EPA approval ‘very soon’ to make COVID-killing claims for surface disinfectants | News

Exclusive: Lonza expects EPA approval ‘very soon’ to make COVID-killing claims for surface disinfectants | News

July 10, 2020 Off By administrator

by

By Siddharth Cavale and Richa Naidu

(Reuters) – Lonza Group AG is in the “last step” of discussions with U.S. regulators for approval to claim that its formulation is effective in killing the novel Coronavirus on surfaces, an executive at the pharmaceutical and chemical giant told Reuters.

Earlier this week, Reckitt Benckiser Group Plc became the first company to win the U.S. Environmental Protection Agency’s approval to market two of its Lysol disinfectant sprays as household COVID-19 killers.

Reuters previously reported that Reckitt had procured a strain of the virus from an independent lab, for testing. The EPA’s approval allows Reckitt to claim that Lysol can kill the novel coronavirus, or the SARS-CoV-2, on surfaces.

Ernesto Lippert, Lonza’s vice president of strategic development and advocacy, told Reuters Thursday that it, too, obtained a strain of SARS-CoV-2 and had tested a range of its formulations in approved EPA labs. He said data shows that the products could indeed kill SARS-CoV-2 on surfaces.

“We are probably be going to be the second one after Reckitt Benckiser to have a range of our products with the actual claim against SARS-CoV-2,” Lippert said, adding that Lonza is in the “last step” of the process and that “EPA’s approval is going to be very soon.”

Reuters could not independently verify Lonza’s discussions with the EPA or the timing on a possible decision by the agency.

An EPA spokesperson said on Friday Lonza was one of several companies to have submitted laboratory data against SARS-CoV-2, but declined to elaborate on the approval timeline.

Lonza is one of a few big chemical companies, along with U.S.-based Stepan Co and Pilot Chemicals, which own chemical formulations that go into many household products. The formulations typically have been pre-tested and EPA- approved for use against a variety of pathogens. Lonza’s current clients include 3M and the maker of Pine Glo kitchen and bathroom cleaner.

The EPA in March issued new guidelines, allowing hundreds of smaller companies to quickly gain regulatory approval without subjecting their products to time-consuming testing.

Applicants with data showing their products are effective against “non-enveloped” viruses won expedited approval to market their products as potentially effective against SARS-CoV-2. The EPA considers “non-enveloped” viruses to be harder-to-kill than even SARS-CoV-2, which is an “enveloped” virus.

That easing of the rules coupled with the licensing means companies can go through an accelerated EPA vetting process than the previous time frame of six months to one year for approval.

Alexandra Dapolito Dunn, assistant administrator of the EPA’s Office of Chemical Safety and Pollution Prevention, said in a statement late March that the move would allow the EPA to better protect public health by assuring…

(Excerpt) To read the full article , click here
Image credit: source